Article
In vivo correction of a TP53 hotspot mutation by base editing induces tumor regression.
2026-05-08
Abstract excerpt
<title>Abstract</title> <p>Despite rapid advances in precision genome editing, most clinical applications have focused on monogenic disorders. In contrast, therapeutic mutation correction in cancer has remained largely unexplored. Here, we demonstrate in vivo correction of the recurrent TP53-R273H hotspot mutation using adenine base editing in a peritoneal cancer mouse model. Liposome-mediated delivery of optimiz...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 03eb43e8-9976-58f8-ae1d-5ec8e685709a
- DOI
- 10.21203/rs.3.rs-9643229/v1
